Leadership / Advisory Board
Professor of Chemistry and of Radiology and of Chemical and Systems Biology at Stanford University, Dr. Carolyn Bertozzi, Ph.D., is also a member of the National Academy of Sciences, the Institute of Medicine, the German Academy of Sciences – Leopoldina, the American Academy of Arts and Sciences and the National Academy of Inventors. Dr. Bertozzi is the recipient of multiple awards, including the Lemelson-MIT Prize, the Albert Hofmann Medal, and a MacArthur Foundation “Genius” Award and is also a Fellow of the American Association for the Advancement of Science. Dr. Bertozzi received her undergraduate degree from Harvard University, a Ph.D. from the University of California at Berkeley. Dr. Bertozzi has been recognized with honorary doctorate degrees from Brown University, Duke University and the Freie University of Berlin.
Dr. Karsdal’s research focuses on the discovery of novel biomarkers and has led to the development of over 15 biochemical assays used for research in the fields of osteoarthritis, fibrosis and osteoporosis. He has published extensively, contributing to over 165 peer-reviewed articles in the areas of osteoarthritis, fibrosis and inflammation. Dr. Karsdal is CEO of Nordic Bioscience and holds the position of Adjunct Professor at the University of Southern Denmark. Dr. Karsdal received a Ph.D. in Bone and Cartilage Pharmacology from the University of Southern Denmark.
Dr. Panitch is a cofounder and an inventor of Symic Bio’s proteoglycan technology. She has over 20 years experience in biopolymer and biomaterials research. She has cofounded three biotechnology companies based on this research including AzERx, acquired by Capstone Therapeutics in 2004, Moerae Matrix, a peptide therapeutic company for which she serves a CSO, in addition to Symic Bio. Dr. Panitch completed a five-year program at Smith College and the University of Massachusetts, Amherst earning a B.A. in Biochemistry and a BS in Chemical Engineering. She went on to earn a Ph.D. in Polymer Science and Engineering from the University of Massachusetts, at Amherst, and the completed postdoctoral research at the Swiss Federal Institute of Technology (ETH) and the University of Zurich. She is a Director for Deliberate Innovation in Life Science in the Burton D. Morgan Center at Purdue University and is the Leslie A Geddes Professor in Bio Engineering and the Vice Provost for Faculty Affairs at Purdue University.
Dr. Wight’s research involves defining roles of proteoglycans in vascular disease, lung disease and autoimmune disease, focusing on how these molecules of the extracellular matrix relate to processes of inflammation. He also studies the potential for proteoglycans in bioengineering vascular tissue. He serves as Director of the Matrix Biology Program at the Benaroya Research Institute and holds the position of Affiliate Professor of Pathology at the University of Washington. Dr. Wight is CEO and President of Matrexa, LLC, a position as Associate Editor of Matrix Biology and a Fellow of the American Heart Association. He received a Diploma of Honor from the University of Patras, Greece and a Ph.D. in Zoology from the University of New Hampshire.